ARCHIVES

No Recision Seen, New Money To Low In Mid-March

This article is from The Cancer Letter archive.

Vol. 02 No. 08 | February 20, 1976

Download PDF Visit The Full Archive

Related Articles

Cancer Advocates Use Benefit Analysis To Press For Funds

May 11, 1990

FDA Approves Gilotrif Tablets in NSCLC, Boehringer Ingelheim’s First Approved Cancer Drug

July 26, 2013

HCFA Renamed In HHS Effort At Medicare, Medicaid Reform.

June 22, 2001

Congress Deluged With Protests From Biomedical Researchers Over Grants Reduction, Budget Cuts

February 15, 1985

Smokers Who Quit Live Longer Than Those Who Spit-Study

May 25, 2007

In Brief: Pediatric Groups Endorse Merger Plan; NCI Charters Consumer Liaison Group

November 13, 1998